Filing Overview
This Form 8-K was filed by Safety Shot, Inc. (Nasdaq: SHOT; warrants: SHOTW), although the request metadata identifies BONK, Inc. The report date is February 27, 2024, and the filing was signed March 1, 2024. The filing principally reports executive changes, related agreements, and resolution of litigation.
Business Context and Reporting Period
The company develops and markets consumer products, including products associated with GBB Drink Lab. This filing is event-driven and does not report quarterly or annual operating results.
Financial and Operating Metrics
- No revenue, profit, cash flow, margin, debt, liquidity, or balance-sheet figures are provided.
- Former CEO Brian S. John will receive $12,500 per month as a transition advisor for an initial three-month term ending June 1, 2024, with a possible additional three-month extension by mutual consent.
- Under the Omnibus Agreement, Mr. John received the right to 10% of proceeds from the company’s sale of any shares of SRM or Chijet owned by the company.
Material Changes and Management Commentary
- Danielle De Rosa was appointed Chief Financial Officer effective March 1, 2024.
- Markita L. Russell resigned as CFO effective February 29, 2024. The filing states that her resignation was not due to any disagreement with the company or management.
- Brian S. John resigned as CEO and from the board on February 28, 2024. The filing states that his resignation was not due to any disagreement.
- Jarrett Boon was appointed CEO effective February 28, 2024. He previously served as Chief Operating Officer and co-founded GBB Drink Lab.
- Dr. Glynn Wilson resigned from the board and as Chairman effective March 1, 2024. John Gulyas became Chairman.
- Certain options were transferred among Mr. John, Mr. Boon, Dr. Wilson, and Mr. Gulyas under the Omnibus Agreement. The filing does not provide the number, exercise prices, or vesting terms of the transferred options.
Risks, Contingencies, and Unusual Items
A lawsuit previously disclosed in the Central District of California, Case No. 2:24-cv-537, has been resolved. The company stipulated to a permanent injunction and final judgment. Activities referenced in the company’s January 3, 2024 press release are prohibited and will not occur.
The filing does not describe the financial amount of any settlement, judgment, legal fees, or other related costs.
Investor Verification Points
- Verify the issuer identity: the filing names Safety Shot, Inc., not BONK, Inc.
- Review the complete Transition Advisory Agreement and Omnibus Agreement, including option-transfer details and the contingent 10% proceeds right.
- Assess the effect of the CEO, CFO, and board leadership changes on strategy, controls, and execution.
- Review the court’s permanent injunction and final judgment to determine the operational activities that are prohibited.
- Confirm any settlement-related costs, contingent obligations, and subsequent financial-statement disclosures, none of which are quantified in this filing.